Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Abdelrahman Ibrahim Abushouk
Ahmed Elmaraezy
Amro Aglan
Reham Salama
Samar Fouda
Rana Fouda
Ammar M. AlSafadi
机构：
[1] Faculty of Medicine,
[2] Ain Shams University,undefined
[3] NovaMed Medical Research Association,undefined
[4] Faculty of Medicine,undefined
[5] Al-Azhar University,undefined
[6] Faculty of Medicine,undefined
[7] Tanta University,undefined
[8] Faculty of Medicine,undefined
[9] Benha University,undefined
[10] Faculty of Medicine,undefined
[11] Zagazig University,undefined
[12] Faculty of Medicine,undefined
[13] Damascus University,undefined
来源：
BMC Neurology | / 17卷
关键词：
Bapineuzumab; Passive immunotherapy; Alzheimer’s disease; Dementia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials
    Abushouk, Abdelrahman Ibrahim
    Elmaraezy, Ahmed
    Aglan, Amro
    Salama, Reham
    Fouda, Samar
    Fouda, Rana
    AlSafadi, Ammar M.
    BMC NEUROLOGY, 2017, 17
  • [2] Cerebrolysin in Mild-to-Moderate Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Clinical Trials
    Gauthier, Serge
    Proano, Jefferson Voltaire
    Jia, Jianping
    Froelich, Lutz
    Vester, Johannes Christophe
    Doppler, Edith
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2015, 39 (5-6) : 332 - 347
  • [3] Safety Analysis of Bapineuzumab in the Treatment of Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Gao, Yaqi
    Guo, Jing
    Zhang, Fang
    Li, Yanfang
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (01) : 40 - 47
  • [4] Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials
    Vandenberghe, Rik
    Rinne, Juha O.
    Boada, Merce
    Katayama, Sadao
    Scheltens, Philip
    Vellas, Bruno
    Tuchman, Michael
    Gass, Achim
    Fiebach, Jochen B.
    Hill, Derek
    Lobello, Kasia
    Li, David
    McRae, Tom
    Lucas, Prisca
    Evans, Iona
    Booth, Kevin
    Luscan, Gerald
    Wyman, Bradley T.
    Hua, Lisa
    Yang, Lingfeng
    Brashear, H. Robert
    Black, Ronald S.
    ALZHEIMERS RESEARCH & THERAPY, 2016, 8
  • [5] Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
    Rik Vandenberghe
    Juha O. Rinne
    Mercè Boada
    Sadao Katayama
    Philip Scheltens
    Bruno Vellas
    Michael Tuchman
    Achim Gass
    Jochen B. Fiebach
    Derek Hill
    Kasia Lobello
    David Li
    Tom McRae
    Prisca Lucas
    Iona Evans
    Kevin Booth
    Gerald Luscan
    Bradley T. Wyman
    Lisa Hua
    Lingfeng Yang
    H. Robert Brashear
    Ronald S. Black
    Alzheimer's Research & Therapy, 8
  • [6] Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease
    Wilcock, GK
    Whitehead, A
    Evans, JG
    Birks, J
    Perdomo, C
    Pratt, RD
    NEUROLOGY, 2001, 56 (08) : A339 - A339
  • [7] Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled Trials
    Tsoi, Kelvin K. F.
    Chan, Joyce Y. C.
    Chan, Felix C. H.
    Hirai, Hoyee W.
    Kwok, Timothy C. Y.
    Wong, Samuel Y. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (01) : 121 - 130
  • [8] Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
    Salloway, Stephen
    Sperling, Reisa
    Fox, Nick C.
    Blennow, Kaj
    Klunk, William
    Raskind, Murray
    Sabbagh, Marwan
    Honig, Lawrence S.
    Porsteinsson, Anton P.
    Ferris, Steven
    Reichert, Marcel
    Ketter, Nzeera
    Nejadnik, Bijan
    Guenzler, Volkmar
    Miloslavsky, Maja
    Wang, Daniel
    Lu, Yuan
    Lull, Julia
    Tudor, Iulia Cristina
    Liu, Enchi
    Grundman, Michael
    Yuen, Eric
    Black, Ronald
    Brashear, H. Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (04): : 322 - 333
  • [9] Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab
    Russu, Alberto
    Samtani, Mahesh N.
    Xu, Steven
    Adedokun, Omoniyi J.
    Lu, Ming
    Ito, Kaori
    Corrigan, Brian
    Raje, Sangeeta
    Liu, Enchi
    Brashear, H. Robert
    Styren, Scot
    Hu, Chuanpu
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (02) : 535 - 546
  • [10] Chinese Medicine for Alzheimer's Disease:A Meta-Analysis of Randomized Controlled Trials
    MA Hang-kun
    LIU Yue
    LI Bo
    ZHANG Ying
    SUN Lin-juan
    XU Feng-qin
    Chinese Journal of Integrative Medicine, 2018, 24 (12) : 938 - 943
12345